Hyperinsulinemia reduces osteoblast activity in vitro via upregulation of TGF-β

[1]  D. Lawlor,et al.  The association between insulin levels and cortical bone: Findings from a cross-sectional analysis of pQCT parameters in adolescents , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  E. Sato,et al.  Characteristics of bone turnover, bone mass and bone strength in Spontaneously Diabetic Torii-Leprfa rats , 2012, Journal of Bone and Mineral Metabolism.

[3]  S. Dooley,et al.  L-carnosine inhibits high-glucose-mediated matrix accumulation in human mesangial cells by interfering with TGF-β production and signalling. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  S. Dooley,et al.  TGF-β1 As Possible Link between Loss of Bone Mineral Density and Chronic Inflammation , 2010, PloS one.

[5]  J. Nyman,et al.  Inhibition of TGF‐β signaling by 1D11 antibody treatment increases bone mass and quality in vivo , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  Chao Wan,et al.  Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition , 2010, Cell.

[7]  Jiro Takito,et al.  Inhibition of STAT1 accelerates bone fracture healing , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[8]  N. Donos,et al.  The effect of diabetes mellitus on osseous healing. , 2010, Clinical oral implants research.

[9]  P. Kongtawelert,et al.  Versican Facilitates Chondrocyte Differentiation and Regulates Joint Morphogenesis* , 2010, The Journal of Biological Chemistry.

[10]  Zhousheng Xiao,et al.  Dose‐Dependent Effects of Runx2 on Bone Development , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  R. Ritchie,et al.  Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone , 2009, PloS one.

[12]  J. Mitsuhashi,et al.  Increased bone resorption may play a crucial role in the occurrence of osteopenia in patients with type 2 diabetes: Possible involvement of accelerated polyol pathway in its pathogenesis. , 2008, Diabetes research and clinical practice.

[13]  S. Fukumoto,et al.  Amelogenin is a negative regulator of osteoclastogenesis via downregulation of RANKL, M-CSF and fibronectin expression in osteoblasts. , 2007, Archives of oral biology.

[14]  P. Vestergaard,et al.  Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis , 2007, Osteoporosis International.

[15]  I. Fariñas,et al.  SATB2 Is a Multifunctional Determinant of Craniofacial Patterning and Osteoblast Differentiation , 2006, Cell.

[16]  T. Wyss-Coray,et al.  Highly sensitive and specific bioassay for measuring bioactive TGF-β , 2006, BMC Cell Biology.

[17]  P. Sassone-Corsi,et al.  ATF4 Is a Substrate of RSK2 and an Essential Regulator of Osteoblast Biology Implication for Coffin-Lowry Syndrome , 2004, Cell.

[18]  M. Young,et al.  Biglycan knockout mice: New models for musculoskeletal diseases , 2002, Glycoconjugate Journal.

[19]  A. Ooshima,et al.  Glucose enhances type IV collagen production in cultured rat glomerular mesangial cells , 1991, Diabetologia.

[20]  T. Taniguchi,et al.  Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. , 2003, Genes & development.

[21]  D. Mercola,et al.  The Transcription Factor EGR-1 Directly Transactivates the Fibronectin Gene and Enhances Attachment of Human Glioblastoma Cell Line U251* , 2000, The Journal of Biological Chemistry.

[22]  F. Collins,et al.  Evidence for a prostate cancer susceptibility locus on the X chromosome. , 1998, Nature Genetics.

[23]  S. Goldstein,et al.  Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice , 1998, Nature Genetics.

[24]  H Kresse,et al.  Interaction of Biglycan with Type I Collagen (*) , 1995, The Journal of Biological Chemistry.

[25]  T Matsumoto,et al.  Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. , 1994, The Journal of biological chemistry.

[26]  F. Reinholt,et al.  Osteopontin--a possible anchor of osteoclasts to bone. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  L. Bonewald,et al.  Characterization of the latent transforming growth factor ß complex in Bone , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  L. Bonewald,et al.  Characterization of the latent transforming growth factor ß complex in Bone , 1990, Journal of Bone and Mineral Research.

[29]  H. Kleinman,et al.  Osteonectin, a bone-specific protein linking mineral to collagen , 1981, Cell.

[30]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.